Neovasc

Neovasc Inc. is a specialty medical device company based in Richmond, Canada, focused on the development, manufacturing, and marketing of products for the cardiovascular marketplace. The company offers innovative solutions, including the Tiara technology for the transcatheter treatment of mitral valve disease and the Neovasc Reducer, designed for the treatment of refractory angina. The Reducer has been commercially available in Europe since 2015, although it is not yet available in the United States. The Tiara device is currently under clinical investigation across multiple regions, including the United States, Canada, and Europe. Neovasc's expertise also extends to pericardial tissue processing and vascular product development, providing comprehensive design and manufacturing solutions to industry partners. Founded in 2000 and originally known as Medical Ventures Corp., Neovasc has positioned itself within a rapidly growing market, focusing on advanced medical technologies to address complex cardiovascular conditions.